Real‐life effectiveness of first‐line anticancer treatments in stage IIIB/IV NSCLC patients: Data from the Czech TULUNG Registry
暂无分享,去创建一个
L. Koubková | J. Krejčí | L. Havel | J. Skřičková | M. Zemanova | K. Brat | M. Pešek | M. Svatoň | M. Hrnčiarik | O. Fischer | M. Bařinová | K. Hurdalkova | H. Čoupková | M. Bratova | J. Krejci